June 27, 2022


UK's fight against animal diseases undermined due to weakened main lab


The fight against animal diseases in the United Kingdom like bird flu could be undermined by the poor state of the UK's main laboratory, public spending watchdogs warned.


Some facilities at the government veterinary base in Weybridge, Surrey, have deteriorated so badly they "are no longer fit for purpose". The National Audit Office (NAO) said delays to its rebuild could limit the UK's response to another disease outbreak. The government said it was taking steps to secure the facility's future.


The Weybridge site, operated by the Animal and Plant Health Agency (APHA), is the UK's main animal health laboratory, and it is there where internationally important research into major animal diseases such as BSE, foot and mouth disease and bird flu is led.


NAO's recent report looks at the UK government's plans to redevelop the site, with the construction of a new science hub due to start in 2027, and whether these plans will offer value for money. The Department for Environment, Food and Rural Affairs originally estimated the rebuild would cost £1.2 billion (US$1.5 billion) but this has now risen to £2.8 billion (US$3.4 billion), a cost that has not yet been approved by HM Treasury.


NAO said there still "remains substantial uncertainty around costs".


Meanwhile, an estimated £197 million (US$241.8 million) of investment between 2020 and 2025 is still needed to maintain the site.


The NAO report stated: "Weybridge is in poor condition, with ageing buildings that need major repair and replacement, and a lack of capacity to carry out science work.


"Defra has allowed its Weybridge site to deteriorate to a state where some of the facilities are no longer fit for purpose. The level of under-investment and poor strategic management of the site has greatly increased the risk and complexity of the redevelopment programme.


"Any delays or difficulty completing the programme may expose APHA's operations to greater risk, potentially limiting its ability to respond effectively to a major disease outbreak."


Gareth Davies, the head of the NAO, added that Defra had "recently put in place many of the right measures to manage the redevelopment successfully, but it will need to navigate many risks to deliver a site that can protect the UK against animal disease outbreaks and demonstrate value for taxpayers".


Back in 2019, Defra said that the decline of the lab could lead to a total loss of capability within the next decade, leaving the UK vulnerable to future animal disease outbreaks.


In response to the NAO report, Defra said the estimated cost of the rebuild would continue to be "refined" and that the NAO review underlined the need for investment in the site. UK Biosecurity Minister Lord Richard Benyon said: "We are proud of Weybridge's long-standing reputation for excellence in science and evidence that safeguards UK biosecurity, as demonstrated by the fact it is the international reference laboratory for a wide range of important pests and diseases.


"It is right that we plan to make significant investments into the site, which is why we have secured £1.4 billion (US$1.7 billion) of funding so that we can continue to attract and retain the best scientists to ensure the UK's protection from this kind of threat for decades to come through world leading facilities."


The APHA lab is currently dealing with the outbreak of highly pathogenic avian influenza H5N1, which has seen more than 100 cases across the UK.



Video >

Follow Us